The Digital Chemist : How Generative AI is Rewriting the Rules of Drug Discovery
Overview
This book outlines how generative AI is transforming pharmaceutical R&D from slow, trial-and-error screening to rapid, computationally driven molecular design. The Productivity Crisis: Generative AI combats the industry's declining efficiency by actively designing purpose-built molecules rather than just evaluating existing chemical libraries. The AI Toolkit: The shift relies on advanced machine learning architectures-including VAEs, GANs, reinforcement learning, and 3D diffusion models-to generate structurally viable candidates. The Data Bottleneck: Because public databases are noisy and biased, successful AI pipelines require rigorous data auditing, transfer learning, and strict synthetic feasibility scoring to tether digital designs to wet-lab reality. The Modern Pipeline: While AI drastically accelerates target identification and de novo hit discovery, expert human chemists remain essential to filter out structural "hallucinations" before physical synthesis begins. Future Frontiers: Generative design is paving the way for complex multi-target drugs (polypharmacology) and ultra-personalized therapies.
This item is Non-Returnable
Customers Also Bought
Details
- ISBN-13: 9786630562781
- ISBN-10: 663056278X
- Publisher: LAP Lambert Academic Publishing
- Publish Date: October 2026
- Dimensions: 9 x 6 x 0.98 inches
- Shipping Weight: 1.29 pounds
- Page Count: 440
Related Categories
